Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation.
Townsend RR, Walton A, Hettrick DA, Hickey GL, Weil J, Sharp ASP, Blankestijn PJ, Böhm M, Mancia G.
EuroIntervention. 2020 May 20;16(1):89-96. doi: 10.4244/EIJ-D-19-00902.
PMID:32038027
Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point.